VF
JUNS

Virtu Financial’s Jupiter Neurosciences JUNS Stock Holding History

Virtu Financial’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50K Buy
3,083
+2,902
+1,603% +$68.6K ﹤0.01% 1224
2026
Q1 		$5K Buy
+181
New +$8.35K ﹤0.01% 1511

Other funds holding JUNS

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return

Virtu Financial's JUNS Position: Q2 2026 in Review

Virtu Financial increased its Jupiter Neurosciences (JUNS) stake by 1,603% in Q2 2026, buying an estimated $68.6K and bringing the position to 3,083 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Virtu Financial first reported a position in JUNS in Q1 2026 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • Virtu Financial held 3,083 shares of Jupiter Neurosciences worth $50K as of Q2 2026.
  • Virtu Financial bought 2,902 Jupiter Neurosciences shares in Q2 2026, an estimated $68.6K.
  • Jupiter Neurosciences made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1224 holding.
  • Virtu Financial first reported a position in Jupiter Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.